Michael Higginbottom
Inventor
Stats
- 12 US patents issued
- 37 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 12 US Patents Issued
- 37 US Applications Filed
- 117 Total Citation Count
- Mar 2, 2021 Most Recent Filing
- Jun 18, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
BIOVITRUM AB | 1
4 | 2007
2008 |
PFIZER PRODUCTS INC. | 1
| 2003
|
Warner-Lambert Company | 2
3 | 2001
2003 |
PFIZER INC. | 1
| 2003
|
PROXIMAGEN LIMITED | 2
7 3 2 1 3 2 1 | 2009
2011 2012 2013 2014 2015 2016 2017 |
ASTRAZENECA AB | 1
4 1 | 2008
2009 2010 |
ASTRAZENECA AB (PUBL) | 6
| 2008
|
CBT DEVELOPMENT LIMITED | 2
| 2007
|
Inventor Addresses
Address | Duration |
---|---|
Caldecote, GB | Aug 06, 15 - Jun 22, 21 |
Cambridge, GB | Nov 14, 02 - Apr 27, 21 |
Cambridgeshire, GB | Oct 29, 02 - May 19, 15 |
Highfields Caldecote, GB | Mar 27, 08 - Oct 05, 10 |
London, GB | Apr 25, 13 - Nov 03, 22 |
Sandwich, DE | Jun 17, 04 - Jun 17, 04 |
Sandwich, GB | Apr 01, 04 - May 06, 04 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 29 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 14 |
C07B: | GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR | 3 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2022/0348,577 | 2022 | CXCR4 Receptor Antagonists | 0 |
11040969 | 2021 | Compounds I | 0 |
10995091 | 2021 | CXCR4 receptor antagonists | 1 |
10988473 | 2021 | Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylate | 0 |
2020/0062,746 | 2020 | PROCESS FOR THE PREPARATION OF (3S,4S)-TETRAHYDROFURAN-3-YL 4-ISOPROPYL-6,7-DIHYDRO-3H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-CARBOXYLATE | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.